We are live on ! Find out more
ECM

EagleClaw Capital Management Portfolio holdings

AUM $714M
1-Year Est. Return 24.24%
This Fund
S&P 500
This Quarter Est. Return
-13.28%
1 Year Est. Return
+24.24%
3 Year Est. Return
+96.54%
5 Year Est. Return
+138.84%
10 Year Est. Return
+573.51%
AUM
$369M
AUM Growth
-$66.7M
Cap. Flow
-$1.35M
Cap. Flow %
-0.37%
Top 10 Hldgs %
34.98%
Holding
135
New
Increased
33
Reduced
58
Closed
9

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$3M
2
CRL icon
Charles River Laboratories
CRL
+$144K
3
TPL icon
Texas Pacific Land
TPL
+$124K
4
AMZN icon
Amazon
AMZN
+$116K
5
HD icon
Home Depot
HD
+$109K

Sector Composition

Rank Sector Weight
1 Technology 18.37%
2 Consumer Discretionary 16.95%
3 Healthcare 13.95%
4 Industrials 11.93%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
51
Colgate-Palmolive
CL
$73.1B
$2.5M 0.68%
31,154
+635
+2% +$49.7K
PCH
52
DELISTED
PotlatchDeltic
PCH
$2.47M 0.67%
55,875
-900
-2% -$46.4K
IBM icon
53
IBM
IBM
$211B
$2.43M 0.66%
17,205
-455
-3% -$61.4K
HON icon
54
Honeywell
HON
$77B
$2.4M 0.65%
14,680
-53
-0.4% -$9.52K
AIG icon
55
American International
AIG
$41.7B
$2.27M 0.62%
44,350
CVS icon
56
CVS Health
CVS
$133B
$2.22M 0.6%
23,912
-25
-0.1% -$2.44K
FISV
57
Fiserv Inc
FISV
$28.8B
$2.12M 0.58%
23,860
-350
-1% -$33.9K
MSGS icon
58
Madison Square Garden
MSGS
$9.48B
$2.11M 0.57%
13,985
+10
+0.1% +$1.62K
NVS icon
59
Novartis
NVS
$297B
$2.1M 0.57%
24,893
+83
+0.3% +$7.28K
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$121B
$2.1M 0.57%
7,440
TXN icon
61
Texas Instruments
TXN
$252B
$1.97M 0.54%
12,845
+125
+1% +$21K
COP icon
62
ConocoPhillips
COP
$147B
$1.89M 0.51%
21,007
+345
+2% +$35.5K
EMR icon
63
Emerson Electric
EMR
$83.9B
$1.84M 0.5%
23,197
-550
-2% -$48.5K
MKC icon
64
McCormick & Company Non-Voting
MKC
$13.7B
$1.79M 0.48%
21,450
-400
-2% -$37.9K
INFL icon
65
Horizon Kinetics Inflation Beneficiaries ETF
INFL
$1.51B
$1.69M 0.46%
59,125
+1,575
+3% +$49.8K
BDX icon
66
Becton Dickinson
BDX
$45.6B
$1.69M 0.46%
6,834
-171
-2% -$43.4K
PFE icon
67
Pfizer
PFE
$143B
$1.47M 0.4%
28,008
-1,726
-6% -$88K
SIVB
68
DELISTED
SVB Financial Group
SIVB
$1.3M 0.35%
3,289
-82
-2% -$38.6K
WMB icon
69
Williams Companies
WMB
$87.5B
$1.25M 0.34%
40,000
AFL icon
70
Aflac
AFL
$64.9B
$1.13M 0.31%
20,463
UNP icon
71
Union Pacific
UNP
$174B
$1.12M 0.3%
5,241
INGR icon
72
Ingredion
INGR
$6.27B
$1.12M 0.3%
12,675
-425
-3% -$38.1K
CSGP icon
73
CoStar Group
CSGP
$11.7B
$1.05M 0.28%
17,310
PEP icon
74
PepsiCo
PEP
$190B
$1.04M 0.28%
6,250
-200
-3% -$33.7K
KO icon
75
Coca-Cola
KO
$377B
$990K 0.27%
15,729
-175
-1% -$11.1K

Similar funds

EagleClaw Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, EagleClaw Capital Management held 135 positions worth $369M, down 15% from $435M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

EagleClaw Capital Management's Q2 2022 filing shows 33 increased, 58 reduced and 9 closed positions. The largest sale was Apple, an estimated $437K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • EagleClaw Capital Management added most to Nike in Q2 2022, an estimated $3M increase.
  • EagleClaw Capital Management's biggest Q2 2022 reduction was Apple, cutting an estimated $437K.
  • EagleClaw Capital Management fully exited Strategy Inc in Q2 2022, selling an estimated $393K.
  • EagleClaw Capital Management's ten largest holdings make up 35% of its $369M portfolio in Q2 2022.
  • EagleClaw Capital Management opened 0 new positions and closed 9 in Q2 2022.
  • EagleClaw Capital Management's portfolio value fell 15% quarter-over-quarter to $369M.

Based on EagleClaw Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.